Tag Archives: REGENT(TM)

Carmine Therapeutics announced today that it has signed a research collaboration agreement with Takeda Pharmaceutical to discover, develop and commercialize transformative non-viral gene therapies for two rare disease targets using Carmine's...

Read More »